Tert-Butylamine → HCID 178449860, compound
Reaction equation
[CH3:1][C:2]1[CH:3]=[N:4][C:5]([CH2:11][S+:12]([O-:24])[C:13]2[NH:14][C:15]3[CH:16]=[CH:17][C:18]([O:22][CH3:23])=[CH:19][C:20]=3[N:21]=2)=[C:6]([CH3:10])[C:7]=1[O:8][CH3:9].[C:25]([NH2:29])([CH3:28])([CH3:27])[CH3:26]>COC(C)(C)C>[C:25]([NH3+:29])([CH3:28])([CH3:27])[CH3:26].[CH3:23][O:22][C:18]1[CH:17]=[CH:16][C:15]2[NH:14][C:13]([S:12]([CH2:11][C:5]3[C:6]([CH3:10])=[C:7]([O:8][CH3:9])[C:2]([CH3:1])=[CH:3][N:4]=3)=[O:24])=[N:21][C:20]=2[CH:19]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Omeprazole (1.0 g, 2.9 mmol) was dissolved in tert-butyl methyl ether (10 ml) at 60-70° C. Tert-butylamine (0.60 g, 8.1 mmol) was added and the mixture was then cooled to room temperature whereupon the product crystallised. The formed precipitate was filtered off and washed with in tert-butyl methyl ether. The title compound was obtained as a white solid.
Workup
- customcrystallised
- filtrationThe formed precipitate was filtered off
- washwashed with in tert-butyl methyl ether
Sources & evidence
- ORD record
- ord-91ed06affda04849935c93e4a82602b2
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07345061B2
Reaction notes
Loading…